Example: Heart Attack

Search clinical trials for: Ipratropium

Total 159 results

NCT04446637

Not yet recruiting

Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD

Conditions: Chronic Obstructive Pulmonary Disease
NCT02755714

Recruiting

Atrovent in Exercise Induced Laryngeal Obstruction (EILO)

Conditions: Exercise Induced Laryngeal Obstruction (EILO)
NCT03747536

Not yet recruiting

Ipratropium Bromide Spray as Treatment for Sialorrhea in Children

Conditions: Sialorrhea
NCT01691079

Completed

Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes

Conditions: Bronchospasm, Exercise-Induced
NCT04167280

Completed

Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma

Conditions: Asthma
NCT00583778

Completed

A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation

Conditions: Asthma
NCT01691482

Completed

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

Conditions: Pulmonary Disease, Chronic Obstructive
NCT01943552

Completed

Ipratropium Bromide in Peri-Operative COPD

Conditions: Pulmonary Disease, Chronic Obstructive
NCT00911651

Completed

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients

Conditions: COPD
NCT00371527

Completed

Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease

Conditions: Bronchitis
NCT00605410

Completed

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

Conditions: Asthma
NCT00202176

Completed

Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT02236169

Completed

Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Pulmonary Disease, Chronic Obstructive
NCT02182856

Completed

Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD

Conditions: Pulmonary Disease, Chronic Obstructive
NCT03480997

Completed

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD

Conditions: COPD
NCT02236182

Completed

Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Pulmonary Disease, Chronic Obstructive
NCT00296946

Completed

Ipratropium Spray for Drooling Saliva in Parkinson's Disease

Conditions: Parkinson's Disease
NCT00381589

Completed

Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide

Conditions: Hypersalivation
NCT01350128

Completed

PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Chronic Obstructive Pulmonary Disease
NCT02235428

Terminated

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

Conditions: Asthma
NCT02172469

Completed

Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Pulmonary Disease, Chronic Obstructive
NCT00928746

Completed

Actuation Indicator Trial in Patients With COPD

Conditions: Pulmonary Disease, Chronic Obstructive
NCT02576626

Completed

Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD

Conditions: COPD
NCT02177344

Completed

Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease

Conditions: Pulmonary Disease, Chronic Obstructive
NCT02260011

Completed

Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease

Conditions: Pulmonary Disease, Chronic Obstructive